Back to search

University of Thessaly (UTH)

Αναδρομική μελέτη αιτιοπαθογένειας πομφολυγωδών νοσημάτων: ανοσοϊστοχημική ανάλυση παραγόντων που συμβάλλουν στη δημιουργία των πομφολυγωδών νοσημάτων

Abstract

dc:description

Autoimmune bullous diseases represent a heterogenous group of skin diseases, which is characterized by blister formation in skin and/or mucosa. Many reports suggest an increasing incidence of autoimmune bullous diseases and new types are continuously recognized. Objective of this study was to investigate the causes and pathogenesis of autoimmune bullous diseases in Central Greece and detect new pathogenic autoantigen. This was a retrospective study. We included all the patients who were hospitalized to the Dermatology Department or visited the Dermatology Outpatient Department of General University Hospital of Larissa with the diagnosis of autoimmune bullous diseases, from January 2002 till December 2017. The diagnosis was based on histopathology, direct and indirect immunofluoresence and detection of circulating autoantibodies by ELISA. We analyzed the epidemiologic data, the medical and drug history before the onset of bullous diseases, as it was supplied by patients’ hospital records. A total of 109 patients with autoimmune bullous diseases (mean age 62.58±23.2 years, M: F ratio 1:1.09) were enrolled. 88 patients were identified with subepidermal and 21 patients with intraepidermal bullous diseases. There were 85 cases of bullous pemphigoid (BP), 1 case of pemphigoid gestianosis (PG), 1 case of linear IgA bullous dermatosis (LAD) and 1 case of mucous membrane pemphigoid (MMP). In Intraepidermal bullous diseases group, 20 patients were diagnosed with pemphigus vulgaris (PV) and 1 with pemphigus vegetans (Pv). Estimated BP incidence was 8.4 cases per 100000 persons per year. Estimated PV incidence was 2.6 cases per 100000 persons per year. 86.4% of BP patients had more than 2 comorbidities, with cardiovascular diseases being the most frequent. Each BP patient used 4.4±2.6 drugs (min 1-max 11). HMG-CoA reductase inhibitors (40%), b-blockers (34.1%), loop diuretics (28.2%) and DDP-4 inhibitors (24.7%) were used with a higher frequency. 55% of PV patients were diagnosed with more than 2 comorbidities. 40% of PV cases presented with dyslipidemia and 35% with diabetes mellitus type II and hypertension. Each PV patient used 3.05±3 drugs (min 0-max 11). HMG-CoA reductase inhibitors (40%), b-blockers (25%), sulfonylurea (25%) and ACE inhibitors/thiazide diuretics (20%) were the most common. BP and PV recorded an increasing incidence during the study. Our findings also demonstrate that a high percentage of BP and PV patients present with multimorbidity and polypharmacy. Recognition of comorbidities and drugs that have been associated with bullous diseases might help the early diagnosis and proper treatment of this group of diseases.

Degree

thesis:*
Grantor dc:publisher
University of Thessaly (UTH)
Year dc:date
2022

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Papadopoulou, Aikaterini
  • Παπαδοπούλου, Αικατερίνη

Subjects

dc:subject × 10

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/51015

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Papadopoulou, Aikaterini; Παπαδοπούλου, Αικατερίνη. Αναδρομική μελέτη αιτιοπαθογένειας πομφολυγωδών νοσημάτων: ανοσοϊστοχημική ανάλυση παραγόντων που συμβάλλουν στη δημιουργία των πομφολυγωδών νοσημάτων. University of Thessaly (UTH), 2022. http://hdl.handle.net/10442/hedi/51015